David Geller
VP Pulmonary and Rare Diseases @Arcturus Therapeutics
Signup · Get unlimited contacts
WORK HISTORY
VP Pulmonary and Rare Diseases @Arcturus Therapeutics
Arcturus Therapeutics a leading clinical-stage messenger RNA medicines company focused on the development of significant opportunities in respiratory and rare diseases. Arcturus has extensive experience in the discovery and development of mRNA medicines and vaccines, and design and utilization of lipid-mediated drug delivery systems. Current programs include an mRNA therapeutic for the urea cycle defect, ornithine transcarbamylase (OTC) deficiency, and an inhaled mRNA replacement strategy targeting cystic fibrosis.
EDUCATION
University of Arizona
Pediatric Pulmonology Fellowship Program
UCLA
Pediatrics Residency Program
Washington University in St. Louis
Bachelor of Arts (B.A.), Biology, General
University of Iowa Roy J. and Lucille A. Carver College of Medicine
MD
SKILLS
ABOUT DAVID GELLER
My experiences as a physician, clinical researcher, aerosol scientist and Pharma medical…
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.